Akari Therapeutics (AKTX) Exchange Rate Effect (2014 - 2025)
Akari Therapeutics (AKTX) reported Exchange Rate Effect of -$3000.0 for Q3 2025, down 250.0% on a YoY basis from $2000.0 in Q3 2024, and down 400.0% sequentially from $1000.0 in Q4 2024.
Akari Therapeutics (AKTX) Exchange Rate Effect (2014 - 2025) Analysis & Trends
Akari Therapeutics (AKTX) has 8 years of Exchange Rate Effect data on file, last reported at -$3000.0 in Q3 2025.
- For the quarter ending Q3 2025, Exchange Rate Effect fell 250.0% year-over-year to -$3000.0; the trailing twelve-month figure through Sep 2025 stood at -$2000.0 (down 300.0% YoY), and the FY2025 full-year result was $1000.0, up 125.0% from the prior year.
- Exchange Rate Effect slipped to -$3000.0 in Q3 2025, from $1000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $6000.0 in Q4 2023 to a low of -$5000.0 in Q1 2024.
- A 3-year average of -$285.71 and a median of -$1000.0 in 2023 frame the typical range for Exchange Rate Effect.
- Across the five-year window, Exchange Rate Effect jumped 300.0% in 2024 and tumbled 250.0% in 2025, its largest moves.
- Tracing AKTX's Exchange Rate Effect over 3 years: stood at $6000.0 in 2023, then sank by 83.33% to $1000.0 in 2024, then sank by 400.0% to -$3000.0 in 2025.
- Business Quant data shows AKTX's Exchange Rate Effect at -$3000.0 in Q3 2025, $1000.0 in Q4 2024, and $2000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 19.32 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | -7.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -3,000.00 |
| Sep 30, 2025 | -3,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Dec 31, 2023 | 6,000.00 |
| Dec 31, 2023 | 6,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Dec 31, 2020 | -21,401.00 |
| Dec 31, 2020 | -21,401.00 |
| Sep 30, 2020 | 275,701.00 |
| Sep 30, 2020 | 275,701.00 |
| Jun 30, 2020 | -5,924.00 |
| Jun 30, 2020 | -5,924.00 |